- Home
- OXY vs RGC Comparison
OXY vs RGC Comparison
Compare OXY & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXY
- RGC
- Stock Information
- Founded
- OXY 1920
- RGC 2014
- Country
- OXY United States
- RGC Hong Kong
- Employees
- OXY N/A
- RGC N/A
- Industry
- OXY Oil & Gas Production
- RGC Medicinal Chemicals and Botanical Products
- Sector
- OXY Energy
- RGC Health Care
- Exchange
- OXY Nasdaq
- RGC Nasdaq
- Market Cap
- OXY 41.3B
- RGC 38.6B
- IPO Year
- OXY N/A
- RGC 2021
- Fundamental
- Price
- OXY $44.73
- RGC $15.05
- Analyst Decision
- OXY Hold
- RGC
- Analyst Count
- OXY 19
- RGC 0
- Target Price
- OXY $51.47
- RGC N/A
- AVG Volume (30 Days)
- OXY 11.0M
- RGC 2.2M
- Earning Date
- OXY 08-06-2025
- RGC 06-30-2025
- Dividend Yield
- OXY 2.15%
- RGC N/A
- EPS Growth
- OXY N/A
- RGC N/A
- EPS
- OXY 2.47
- RGC N/A
- Revenue
- OXY $27,553,000,000.00
- RGC N/A
- Revenue This Year
- OXY $0.42
- RGC N/A
- Revenue Next Year
- OXY $3.94
- RGC N/A
- P/E Ratio
- OXY $18.12
- RGC N/A
- Revenue Growth
- OXY 2.02
- RGC N/A
- 52 Week Low
- OXY $34.79
- RGC $0.09
- 52 Week High
- OXY $61.35
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- OXY 54.75
- RGC 46.48
- Support Level
- OXY $42.96
- RGC $13.51
- Resistance Level
- OXY $44.55
- RGC $18.41
- Average True Range (ATR)
- OXY 1.21
- RGC 1.91
- MACD
- OXY -0.00
- RGC -0.14
- Stochastic Oscillator
- OXY 61.05
- RGC 19.77
About OXY Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 52% oil and natural gas liquids and 48% natural gas.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.